Biotinylation-based Lateral Flow for Total Bacteria (2025)

💡 Application Note: This study establishes a universal biotinylation-based LFA platform. The methodology described is fully compatible with Due Bio’s Streptavidin-Biotin Universal Strips.

Title: Biotinylation-based lateral flow assays for pathogenic and total bacteria detection

Source: Analytica Chimica Acta (Elsevier) (Feb 2025)


Abstract

It is highly desirable to concurrently evaluate both pathogenic and total bacteria in water and food environments. As a point-of-care platform for biochemical tests, lateral flow assay (LFA) has been widely used for pathogenic bacteria due to its portability and fast time of outcome. However, traditional LFA was unable to detect total bacteria due to the lack of a universal antibody that could bind all the bacteria. Here, we used sulfo–NHS–biotin to label nonspecifically the lipoprotein of bacterial surface. Thus, a biotinylation-based LFA was established for total bacteria detection. Taking the advantage of the universal recognition reaction between the biotin and streptavidin, we established biotinylation-based LFAs for both pathogenic and total bacteria detection without the de novo preparation of the test strips.

Full Text Access

View Abstract on ADS / Elsevier

TL
Global Agent · Duebio (TiosBio) · 20+ Years in IVD
IVD industry veteran specializing in CRISPR Cas12/Cas13 detection, RAA isothermal amplification, lateral flow assays, microfluidic PCR, TRF immunoassays, and OEM/ODM IVD development for global distributors. Duebio is the international trade brand of TiosBio, a Chinese IVD manufacturer with 20+ years of experience.

Leave a Comment